<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02912195</url>
  </required_header>
  <id_info>
    <org_study_id>00001</org_study_id>
    <nct_id>NCT02912195</nct_id>
  </id_info>
  <brief_title>Intravenous Lidocaine Versus Morphine for Severe Pain in the ED</brief_title>
  <official_title>Intravenous Lidocaine Versus Provider Chosen Dose of Morphine for the Treatment of Severe Pain in the Emergency Department: An Open-label Randomized Controlled Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alameda Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alameda Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: Evaluate the analgesic efficacy of intravenous (IV) lidocaine versus provider
      chosen dose of IV morphine for the treatment of severe pain in the emergency department.

      Study design: Open-label, randomized controlled pilot study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: The purpose of this pilot study is to determine the analgesic efficacy of
      intravenous lidocaine versus morphine for the treatment of severe pain in the emergency
      department (ED).

      Study design: Open-label, randomized, controlled pilot trial. Participants: Investigators and
      research assistants will recruit patients ≥18 years old with severe pain (NRS ≥7) and an
      anticipated stay in the emergency department ≥1 hour. A sample size calculation was performed
      and 32 patients will be enrolled.

      Intervention: After a trained research assistant obtains written informed consent, eligible
      participants will be randomized to the intravenous lidocaine or morphine arms of the study.
      In the intravenous lidocaine arm, patients will receive IV lidocaine (75 mg if &lt;50kg, 100 mg
      if 50 - 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag
      followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 - 100 kg, and 150 mg
      if &gt;100 kg). In the morphine arm, the ED provider will choose an appropriate dose of morphine
      for the patient. At 20 and 40 minutes, the participants will be asked &quot;Would you like
      additional pain medication?&quot;. Participants responding in the affirmative will receive
      morphine 4 mg IV.

      Data collection: The trained research assistant will collect data on the patients' pain
      scores, side effects, and rescue morphine.

      Statistical analysis: Investigators will perform descriptive statistics and compare pain
      scores and pain relief at each time point with unpaired t-tests.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 60 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 40 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score (NRS 0-10)</measure>
    <time_frame>At 50 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>At 10 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 10 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>at 20 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 20 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>at 30 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 30 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain relief</measure>
    <time_frame>At 40 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 40 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief</measure>
    <time_frame>At 50 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 50 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Relief</measure>
    <time_frame>At 60 minutes</time_frame>
    <description>Pain NRS at 0 minutes minus pain NRS at 60 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion requiring rescue medications</measure>
    <time_frame>At 20 and 40 minutes</time_frame>
    <description>The proportion of patients requiring rescue IV morphine at 20 and 40 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>60 minutes</time_frame>
    <description>The proportion of patients saying, &quot;Yes&quot; to &quot;Would you have this pain medication again for similar pain?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>0-60 minutes</time_frame>
    <description>Participants will be observed for the following adverse events and side effects: seizure, bradyarrhythmias, hyper or hypotension, perioral numbness, tinnitus, metallic taste, other, hypotension, hypoxia, nausea, vomiting, itching, or other side effects. Participants have the opportunity to report other side effects during the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Intravenous lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive IV lidocaine (75 mg if &lt;50kg, 100 mg if 50 - 100 kg, and 150 mg if &gt;100 kg) over 10 minutes in a 100 mL normal saline minibag followed by a 50 minute IV lidocaine drip (75 mg if &lt;50kg, 100 mg if 50 - 100 kg, and 150 mg if &gt;100 kg) in a 100 mL normal saline minibag.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ED provider will choose an appropriate dose of intravenous morphine for the patient.
At 20 and 40 minutes, participants can elect to receive morphine 4mg IV as a rescue analgesic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous lidocaine</intervention_name>
    <description>Intravenous lidocaine drip over 10 minutes followed by intravenous lidocaine drip over 50 minutes</description>
    <arm_group_label>Intravenous lidocaine</arm_group_label>
    <other_name>lignocaine</other_name>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous morphine</intervention_name>
    <description>Emergency department provider chooses appropriate dose of intravenous morphine</description>
    <arm_group_label>Morphine</arm_group_label>
    <other_name>duramorph</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has severe pain (NRS ≥7)

          -  Subject has anticipated ED stay of ≥1 hour

        Exclusion Criteria:

          -  High acuity trauma patients

          -  Patients deemed to critically ill by ED provider

          -  Active psychosis

          -  Pregnancy

          -  History of heart block or bradycardia

          -  Allergy to lidocaine or amide type local anesthetic

          -  History of seizures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Herring, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alameda Health System, Highland Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alameda Health System, Highland Hospital</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2016</study_first_submitted>
  <study_first_submitted_qc>September 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <last_update_submitted>September 26, 2016</last_update_submitted>
  <last_update_submitted_qc>September 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alameda Health System</investigator_affiliation>
    <investigator_full_name>Eben Clattenburg</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

